Loading…
Loading grant details…
| Funder | British Heart Foundation |
|---|---|
| Recipient Organization | Imperial College London |
| Country | United Kingdom |
| Start Date | May 20, 2021 |
| End Date | Sep 13, 2023 |
| Duration | 846 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | PG/21/10422 |
Heme oxygenase-1 (HO-1) is a critical enzyme for vascular health and disease and a marker of hemorrhage in ruptured coronary plaques and hemorrhagic stroke. Yet it lacks a good detection method for live cells or tissues. HO-1 imaging would add enormously to diagnostic coronary imaging.
Detection and imaging of HO-1 would allow for a full preclinical investigation of its function allowing for translation of HO-1 activity as a biomarker to improve clinical management of myocardial infarction, stroke and ruptured aortic aneurysm.
Previously funded by the BHF, we successfully incorporated coumarin in a heme analogue such that it becomes fluorescent on release by HO-1 activity. In this new proposal, the utility of a wide range of HO-1 sensitive fluorophores will be explored.
These will be easily generated by addition of an ethyne (a small and highly specific group) to the Protoporphyrin-IX ring at the alpha-carbon position.
The new probes will be evaluated spectroscopically, in cell-free systems and in cultured human and mouse cells, and then validated in an easily-imaged mouse model of hematoma. This will facilitate development of probes for clinical application in imaging and point-of-care diagnosis.
Imperial College London
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant